Skip to main content
Erschienen in: Journal of Neuro-Oncology 3/2009

01.07.2009 | Clinical Study - Patient Study

Epilepsy in cerebral glioma: timing of appearance and histological correlations

verfasst von: Anna Rosati, Alessia Tomassini, Bianca Pollo, Claudia Ambrosi, Andreas Schwarz, Alessandro Padovani, Bruno Bonetti

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose A prospective study of patients with glioma was carried out. Special attention was paid to the first seizure, to the histology, and to the efficacy and prophylactic role of antiepileptic drugs (AEDs). Prognostic factors were analyzed. Methods Between February 1st 2004 and April 1st 2006 patients who underwent surgical treatment at the Neurosurgery Department of Bolzano for primary or recurrent glioma were prospectively followed until April 1st 2007. Seizures at onset occurring in the absence of interictal epileptiform abnormalities were regarded as remote symptomatic seizures and not treated. Results Sixty-four individuals were registered in the study; epilepsy diagnosis was made in 27 cases and in 24 of these seizures were the onset symptom. The correlation with histological grading showed that seizures were more frequent in low-grade glioma and in secondary glioblastoma. Although epilepsy was less frequent in high-grade glioma, in these patients seizures were more difficult to control. Poor seizure control was associated with motor and sensitive focal seizures and presence of neurological deficit. Patients without epilepsy and not taking AEDs never developed seizures during the follow-up. Discussion Our study clearly shows that epilepsy is more frequent in low-grade gliomas but seizures are more difficult to control in high-grade gliomas. In both cases seizures are a quite exclusive symptom at the onset that never appears during the stable course of the disease. Amongst glioblastoma multiforme (GBM), epilepsy is more frequent in GBM developing through progression from low-grade astrocitoma. Moreover, our study strongly indicates that the prophylactic use of AEDs in glioma is not justified.
Literatur
1.
Zurück zum Zitat Fisher RS, Van Boas Emde, Blume W, Elger C, Genton P, Lee P, Engel J (2005) Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46:470–472. doi:10.1111/j.0013-9580.2005.66104.x PubMedCrossRef Fisher RS, Van Boas Emde, Blume W, Elger C, Genton P, Lee P, Engel J (2005) Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46:470–472. doi:10.​1111/​j.​0013-9580.​2005.​66104.​x PubMedCrossRef
2.
Zurück zum Zitat Siomin V, Angelov L, Li L, Vogelbaum MA (2005) Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors. J Neurooncol 74(2):211–215. doi:10.1007/s11060-004-6912-4 PubMedCrossRef Siomin V, Angelov L, Li L, Vogelbaum MA (2005) Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors. J Neurooncol 74(2):211–215. doi:10.​1007/​s11060-004-6912-4 PubMedCrossRef
3.
Zurück zum Zitat Glantz MJ, Cole BF, Friedberg MH, Lathi E, Choy H, Furie K, Akerley W, Wahlberg L, Lekos A, Louis S (1996) A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumours. Neurology 46:985–991PubMed Glantz MJ, Cole BF, Friedberg MH, Lathi E, Choy H, Furie K, Akerley W, Wahlberg L, Lekos A, Louis S (1996) A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumours. Neurology 46:985–991PubMed
4.
Zurück zum Zitat Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumours. Reported of the Quality Standard Subcommittee of the American Academy of Neurology. Neurology 54:1886–1893PubMed Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumours. Reported of the Quality Standard Subcommittee of the American Academy of Neurology. Neurology 54:1886–1893PubMed
5.
Zurück zum Zitat Sirven JI, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS (2004) Seizure prophylaxis in patients with brain tumors: a metanalysis. Mayo Clin Proc 79:1489–1494PubMedCrossRef Sirven JI, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS (2004) Seizure prophylaxis in patients with brain tumors: a metanalysis. Mayo Clin Proc 79:1489–1494PubMedCrossRef
10.
Zurück zum Zitat Wick W, Menn O, Meisner C, Steinbach J, Hermisson M, Tatagiba M, Weller M (2005) Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long? Onkologie 28:391–396. doi:10.1159/000086375 PubMedCrossRef Wick W, Menn O, Meisner C, Steinbach J, Hermisson M, Tatagiba M, Weller M (2005) Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long? Onkologie 28:391–396. doi:10.​1159/​000086375 PubMedCrossRef
14.
Zurück zum Zitat Kleihues P, Cavenee WK (2000) In: World Health Organization classification of tumours: pathology and genetics of tumours of the nervous system. IARC, Lyon, pp 9–54 Kleihues P, Cavenee WK (2000) In: World Health Organization classification of tumours: pathology and genetics of tumours of the nervous system. IARC, Lyon, pp 9–54
15.
Zurück zum Zitat Kleihues P, Burger PC, Aldape KD, Brat DJ, Biernat W, Bigner DD, Nakazato Y, Plate KH, Giangaspero F, von Deimling A, Ohgaki H, Cavenee WK (2007) In: World Health Organization classification of tumours of central nervous system. IARC, Lyon, pp 33–49 Kleihues P, Burger PC, Aldape KD, Brat DJ, Biernat W, Bigner DD, Nakazato Y, Plate KH, Giangaspero F, von Deimling A, Ohgaki H, Cavenee WK (2007) In: World Health Organization classification of tumours of central nervous system. IARC, Lyon, pp 33–49
16.
Zurück zum Zitat Pope WB, Sayre J, Perlina A, Villablanca JP, Mischel PS, Cloughesy TF (2005) MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol 26(10):2466–2474PubMed Pope WB, Sayre J, Perlina A, Villablanca JP, Mischel PS, Cloughesy TF (2005) MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol 26(10):2466–2474PubMed
17.
Zurück zum Zitat Rasmussen TB (1975) Surgery of epilepsy associated with brain tumors. Adv Neurol 8:227–239PubMed Rasmussen TB (1975) Surgery of epilepsy associated with brain tumors. Adv Neurol 8:227–239PubMed
19.
Zurück zum Zitat Ruegg S (2002) Dexamethasone/phenytoin interactions: neurooncological concerns. Swiss Med Wkly 132:425–426PubMed Ruegg S (2002) Dexamethasone/phenytoin interactions: neurooncological concerns. Swiss Med Wkly 132:425–426PubMed
20.
Zurück zum Zitat Lund M (1952) Epilepsy in association with intracranial tumours. Acta Psychiatr Neurol Scand Suppl 81:1–149 Lund M (1952) Epilepsy in association with intracranial tumours. Acta Psychiatr Neurol Scand Suppl 81:1–149
Metadaten
Titel
Epilepsy in cerebral glioma: timing of appearance and histological correlations
verfasst von
Anna Rosati
Alessia Tomassini
Bianca Pollo
Claudia Ambrosi
Andreas Schwarz
Alessandro Padovani
Bruno Bonetti
Publikationsdatum
01.07.2009
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 3/2009
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-009-9796-5

Weitere Artikel der Ausgabe 3/2009

Journal of Neuro-Oncology 3/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.